Hiroshi Sekiyama Selected Research

Hiroshi Sekiyama Research Topics

Disease

9	Pain (Aches) 01/2017 - 02/2002
5	Neuralgia (Stump Neuralgia) 01/2011 - 05/2004
3	Hyperalgesia 02/2006 - 05/2004
2	Arthritis (Polyarthritis) 01/2017 - 02/2006
2	Acute Coronary Syndrome 01/2017 - 01/2013
2	Postoperative Pain 01/2017 - 09/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 01/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2015 - 07/2011
2	Hypothermia 02/2007 - 05/2002
2	Postherpetic Neuralgia 02/2006 - 01/2004
2	Nausea 02/2006 - 04/2003
1	Insulin Resistance 01/2017
1	Inflammation (Inflammations) 01/2017
1	Arteriosclerosis 01/2015
1	Atrial Fibrillation 01/2014
1	Heart Failure 01/2014
1	Cardiac Tamponade 07/2013
1	Myocardial Infarction 01/2013
1	Hypersensitivity (Allergy) 09/2007
1	Intervertebral Disc Displacement (Herniated Disc) 02/2006
1	Headache (Headaches) 02/2006
1	Fibromyalgia (Fibrositis) 02/2006
1	Pruritus (Itching) 02/2006
1	Rheumatic Fever (Acute Articular Rheumatism) 02/2006
1	Vomiting 02/2006
1	Pelvic Pain 02/2006
1	Failed Back Surgery Syndrome 02/2006
1	Chronic Pain 02/2006
1	Intracranial Hypertension 05/2002
1	Pulmonary Atelectasis 05/2002
1	Reye Syndrome (Reye's Syndrome) 05/2002
1	Thrombocytopenia (Thrombopenia) 05/2002
1	Hypokalemia 05/2002
1	Hyperventilation 05/2002
1	Hypohidrosis 02/2002
1	Congenital Pain Insensitivity 02/2002
1	Malignant Hyperthermia 02/2002

Drug/Important Bio-Agent (IBA)

3	PotassiumIBA 01/2017 - 05/2002
3	Analgesics (Analgesic Drugs)IBA 01/2017 - 02/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 05/2002
2	Insulin (Novolin)FDA Link 01/2017 - 05/2002
2	Lidocaine (Xylocaine)FDA LinkGeneric 01/2017 - 01/2011
2	Local AnestheticsIBA 01/2017 - 01/2011
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2014 - 07/2013
2	Proteins (Proteins, Gene)FDA Link 09/2007 - 10/2005
2	Pharmaceutical PreparationsIBA 02/2006 - 02/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	CarrageenanIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015
1	oxidized low density lipoproteinIBA 01/2015
1	Malondialdehyde (Propanedial)IBA 01/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2015
1	CreatinineIBA 01/2014
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2013
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2013
1	antineoplaston A10 (A 10)IBA 09/2011
1	omega-Chloroacetophenone (Mace)IBA 07/2011
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2007
1	Clonidine (ST 155)FDA LinkGeneric 09/2007
1	dimemorfan (AT 17)IBA 02/2007
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 02/2006
1	Ketamine FDA LinkGeneric 02/2006
1	Morphine (MS Contin)FDA LinkGeneric 02/2006
1	Phentolamine (Z-Max)FDA LinkGeneric 02/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2005
1	Meloxicam (Mobic)FDA LinkGeneric 10/2005
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2005
1	Glial Fibrillary Acidic ProteinIBA 05/2004
1	Methylprednisolone FDA LinkGeneric 05/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2004
1	Adenosine (Adenocard)FDA LinkGeneric 01/2004
1	triphosphoric acid (triphosphate)IBA 01/2004
1	barbituric acid (barbiturate)IBA 05/2002
1	Anesthetics (Anesthetic Agents)IBA 02/2002
1	3-(2-carboxyindol-3-yl)propionic acidIBA 02/2002

Therapy/Procedure

4	Therapeutics 01/2017 - 05/2002
2	Local Anesthesia 01/2017 - 01/2011
2	Ligation 10/2005 - 05/2004
1	Injections 01/2017
1	Aftercare (After-Treatment) 01/2017
1	Drug Therapy (Chemotherapy) 01/2011
1	Rewarming 02/2007
1	Intravenous Infusions 01/2004
1	Cesarean Section (Caesarean Section) 04/2003
1	Spinal Anesthesia 04/2003
1	Fluid Therapy (Oral Rehydration Therapy) 05/2002
1	Artificial Respiration (Mechanical Ventilation) 05/2002
1	Induced Hypothermia 05/2002
1	Anesthesia 02/2002